XXII 22nd Century Group Inc.

+0.05  (+2%)
Previous Close 2.02
Open 2.04
Price To Book 3.7
Market Cap 258046200
Shares 124,660,000
Volume 434,096
Short Ratio 15.69
Av. Daily Volume 1,553,456

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Latest News

  1. Edited Transcript of XXII earnings conference call or presentation 8-May-19 8:00pm GMT
  2. 3 Marijuana Stocks to Avoid Like the Plague in May
  3. 22nd Century: 1Q Earnings Snapshot
  4. 22nd Century Files 2019 First Quarter Report and Announces Conference Call to Provide Business Update
  5. 7 Marijuana Stocks That Are Bleeding Cash
  6. 5 Best Pot Stocks in April -- Are They Buys Now?
  7. 22nd Century Group Announces FDA Inspection For Its Pre-Market Tobacco Application
  8. 22nd Century’s Pre-Market Tobacco Application for VLN™ Cigarettes Advances with Completed FDA Inspection
  9. Investors Who Bought 22nd Century Group (NYSEMKT:XXII) Shares Three Years Ago Are Now Up 120%
  10. Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders
  11. 22nd Century Group Hires Former Imperial Brands Head of Regulatory Science
  12. Cannabis Stocks to Watch
  13. 22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis
  14. These 5 Pot Stocks Lost at Least 15% in the First Quarter
  15. These Worst-Performing Pot Stocks Fell at Least 20% in March
  16. 22nd Century Group Issues Annual Letter to Shareholders
  17. 22nd Century’s New Study Confirms Very Low Nicotine Content Cigarettes Result in 97% Less Nicotine in Smoker’s Bloodstream
  18. Lifshitz & Miller LLP Announces Investigation of 22nd Century Group, Activision Blizzard, Inc., Astec Industries, Inc., Avon Products, Inc., Axogen, Inc., Everquote Inc. and Health Insurance Innovations, Inc.
  19. 22nd Century Group, Inc. (XXII), Arlo Technologies, Inc. (ARLO), Micron Technology, Inc. (MU) Class Action Reminder Bronstein, Gewirtz & Grossman, LLC
  20. Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against 22nd Century Group, Inc. (XXII)